{
    "Trade/Device Name(s)": [
        "Easy Plus II Blood Glucose Monitoring System, Model 6276-S",
        "Easy Plus II Multi Blood Glucose Monitoring System, Model 6276-M",
        "Smartest Persona II Blood Glucose Monitoring System, Model 6276-S",
        "Smartest Persona II Multi Blood Glucose Monitoring System, Model 6276-M"
    ],
    "Submitter Information": "Biotest Medical Corporation",
    "510(k) Number": "K133509",
    "Predicate Device Reference 510(k) Number(s)": [
        "K100560"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "January 20, 2014",
    "Summary Letter Received Date": "January 22, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood (finger and forearm)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Easy Plus II Blood Glucose Meter",
        "Easy Plus II Multi Blood Glucose Multi Meter",
        "Smartest Persona II Blood Glucose Meter",
        "Smartest Persona II Multi Blood Glucose Multi Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical measurement (based on electrical current produced by glucose reaction with test strip reagent)",
        "Glucose oxidase"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Kit",
        "Analyzer",
        "Meter",
        "Test strip",
        "Control solution",
        "Lancing device",
        "Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for Easy Plus II and Smartest Persona II Blood Glucose Monitoring Systems for quantitative glucose measurement using electrochemical technology in capillary blood from finger and forearm.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood drawn from finger and forearm; for self-testing by single users or multi-patient use in professional healthcare settings (not for diagnosis, screening, or neonatal use), as an aid to monitor effectiveness of diabetes control.",
    "fda_folder": "Clinical Chemistry"
}